Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2014, Article ID 415815, 6 pages
http://dx.doi.org/10.1155/2014/415815
Research Article

Off-Label Medicine Use in Pediatric Inpatients: A Prospective Observational Study at a Tertiary Care Hospital in India

1Department of Pharmacology and Clinical Pharmacy, K.B. Institute of Pharmaceutical Education and Research, GH 6, Sector 23, Gandhinagar, Gujarat 382024, India
2Department of Pharmacology, Smt. N.H.L. Municipal Medical College, Sheth V.S. General Hospital, Ellisbridge, Ahmedabad, Gujarat 380006, India

Received 23 July 2014; Revised 17 November 2014; Accepted 17 November 2014; Published 25 November 2014

Academic Editor: Julie Blatt

Copyright © 2014 Mohd Masnoon Saiyed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Dunne, “The European Regulation on medicines for paediatric use,” Paediatric Respiratory Reviews, vol. 8, no. 2, pp. 177–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Kimland and V. Odlind, “Off-label drug use in pediatric patients,” Clinical Pharmacology & Therapeutics, vol. 91, no. 5, pp. 796–801, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Cuzzolin, A. Atzei, and V. Fanos, “Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety,” Expert Opinion on Drug Safety, vol. 5, no. 5, pp. 703–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Turner, A. Longworth, A. J. Nunn, and I. Choonara, “Unlicensed and off label drug use in paediatric wards: prospective study,” British Medical Journal, vol. 316, no. 7128, pp. 343–345, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Jain, S. B. Bavdekar, N. J. Gogtay, and P. A. Sadawarte, “Off-label drug use in children,” Indian Journal of Pediatrics, vol. 75, no. 11, pp. 1133–1136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. B. Bavdekar, P. A. Sadawarte, N. J. Gogtay, S. S. Jain, and S. Jadhav, “Off-label drug use in a Pediatric Intensive Care Unit,” Indian Journal of Pediatrics, vol. 76, no. 11, pp. 1113–1118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Pandolfini, P. Impicciatore, D. Provasi et al., “Off-label use of drugs in Italy: a prospective, observational and multicentre study,” Acta Paediatrica, vol. 91, no. 3, pp. 339–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Knopf, I.-K. Wolf, G. Sarganas, W. Zhuang, W. Rascher, and A. Neubert, “Off-label medicine use in children and adolescents: results of a population-based study in Germany,” BMC Public Health, vol. 13, no. 1, article 631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Conroy, M. P. Raffaelli, F. Rocchi et al., “Survey of unlicensed and off label drug use in paediatric wards in European countries,” British Medical Journal, vol. 320, no. 7227, pp. 79–82, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. National Formulary of India, 4th edition, 2011, http://cdsco.nic.in/writereaddata/NFI_2011.pdf.
  11. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment, Norwegian Institute of Public Health, Oslo, Norway, 14th edition, 2011.
  12. R. Harbour and J. Miller, “A new system for grading recommendations in evidence based guidelines,” British Medical Journal, vol. 323, no. 7308, pp. 334–336, 2001. View at Google Scholar · View at Scopus
  13. E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies,” Journal of Clinical Epidemiology, vol. 61, no. 4, pp. 344–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Langerová, J. Vrtal, and K. Urbánek, “Incidence of unlicensed and off-label prescription in children,” Italian Journal of Pediatrics, vol. 40, no. 1, article 12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Dos Santos and I. Heineck, “Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications,” Farmacia Hospitalaria, vol. 36, no. 4, pp. 180–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Carnovale, V. Conti, V. Perrone et al., “Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches,” European Journal of Pediatrics, vol. 172, no. 12, pp. 1679–1685, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Schirm, H. Tobi, and L. T. W. de Jong-van den Berg, “Risk factors for unlicensed and off-label drug use in children outside the hospital,” Pediatrics, vol. 111, no. 2, pp. 291–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. G. W. Jong, I. A. Eland, M. C. J. M. Sturkenboom, J. N. van den Anker, and B. H. C. Stricker, “Unlicensed and off-label prescription of respiratory drugs to children,” European Respiratory Journal, vol. 23, no. 2, pp. 310–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ekins-Daukes, J. S. McLay, M. W. Taylor, C. R. Simpson, and P. J. Helms, “Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care,” British Journal of Clinical Pharmacology, vol. 56, no. 1, pp. 92–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Conroy and V. Peden, “Unlicensed and off label analgesic use in paediatric pain management,” Paediatric Anaesthesia, vol. 11, no. 4, pp. 431–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. P. H. Novak, S. Ekins-Daukes, C. R. Simpson, R. M. Milne, P. Helms, and J. S. McLay, “Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care,” British Journal of Clinical Pharmacology, vol. 59, no. 6, pp. 712–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. T. F. Bazzano, R. Mangione-Smith, M. Schonlau, M. J. Suttorp, and R. H. Brook, “Off-label prescribing to children in the United States outpatient setting,” Academic Pediatrics, vol. 9, no. 2, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Morais-Almeida and A. J. Cabral, “Off-label prescribing for allergic diseases in pre-school children,” Allergologia et Immunopathologia, vol. 42, no. 4, pp. 342–347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. National Asthma Education and Prevention Program and Third Expert Panel on the Diagnosis and Management of Asthma, Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2014, http://www.ncbi.nlm.nih.gov/books/NBK7232/.
  25. A. I. De Sutter, M. L. van Driel, A. A. Kumar, O. Lesslar, and A. Skrt, “Oral antihistamine-decongestant-analgesic combinations for the common cold,” Cochrane Database of Systematic Reviews, vol. 2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Meremikwu and A. Oyo-Ita, “Paracetamol for treating fever in children,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003676, 2002. View at Google Scholar · View at Scopus
  27. B. Carter and Z. Fedorowicz, “Antiemetic treatment for acute gastroenteritis in children: an updated Cochrane systematic review with meta-analysis and mixed treatment comparison in a Bayesian framework,” BMJ Open, vol. 2, no. 4, Article ID e000622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Prasad, P. R. Krishnan, K. Al-Roomi, and R. Sequeira, “Anticonvulsant therapy for status epilepticus,” British Journal of Clinical Pharmacology, vol. 63, no. 6, pp. 640–647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Hoppu, G. Anabwani, F. Garcia-Bournissen et al., “The status of paediatric medicines initiatives around the world—what has happened and what has not?” European Journal of Clinical Pharmacology, vol. 68, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Selvarajan, M. George, S. S. Kumar, and S. A. Dkhar, “Clinical trials in India: where do we stand globally?” Perspectives in Clinical Research, vol. 4, no. 3, pp. 160–164, 2013. View at Publisher · View at Google Scholar